IL18 and acute kidney injury: In current clinical practice, AKI is usually diagnosed by measuring urine and serum biomarkers, including creatinine, blood urea nitrogen (BUN), interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1), and neutrophil galatinase-associated lipocalin (NGAL)16–19.